DEA Nods to Lab's Bid for Controlled Drug Production
Published Date: 7/17/2025
Notice
Summary
Cerilliant Corporation wants to get official permission to make large amounts of certain controlled substances. This affects anyone who works with these drugs, like researchers and medicine makers. If approved, Cerilliant can start producing soon, helping labs get the materials they need without delays or extra costs.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Cerilliant Seeks Bulk Manufacturer Registration
Cerilliant Corporation has applied to be registered as a bulk manufacturer of certain controlled substances. If approved, Cerilliant could produce large quantities of those drugs, which the notice says would help researchers, laboratories, and medicine makers get the materials they need without delays or extra costs.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526 — Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128 — Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-13705 — Importer of Controlled Substances Application: Benuvia Operations, LLC.
Benuvia Operations, LLC wants to become an official importer of certain controlled substances like marijuana extract and psilocybin. People and companies involved with these drugs can share their thoughts or ask for a hearing by August 6, 2026. This move could shake up who gets to bring these substances into the U.S., so keep an eye on the deadline if you’re interested!
2026-13581 — Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I
Starting July 6, 2026, the DEA plans to temporarily put three substances related to 7-hydroxymitragynine—Mitragynine Pseudoindoxyl, MGM-15, and MGM-16—into Schedule I, the strictest drug category. This means anyone making, selling, or using these chemicals will face tough legal rules and penalties. The move aims to control these substances quickly while the DEA studies them further, affecting businesses and researchers handling these compounds.
2026-13580 — Schedules of Controlled Substance: Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I
Starting July 6, 2026, the DEA plans to temporarily put 7-hydroxymitragynine above a certain amount into Schedule I, meaning it’s treated like the most tightly controlled drugs. This affects anyone who makes, sells, studies, or even just has this substance, bringing strict rules and penalties. The move aims to keep people safe while the government figures out the long-term plan.
2026-13364 — Schedules of Controlled Substances: Temporary Placement of 5,6- Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act
Starting July 1, 2026, the DEA is temporarily putting four new substances—5,6-dichloro brorphine, 5,6-dichloro desmethylchlorphine, N-propionitrile chlorphine, and spirochlorphine—into Schedule I, the strictest drug category. This means anyone making, selling, or using these chemicals will face tough legal rules and penalties. The move helps keep these potentially dangerous drugs off the streets while the DEA studies them further.
Previous / Next Documents
Previous: 2025-13445 — City of Holyoke Gas & Electric Department; Notice of Effectiveness of Withdrawal of Notices of Intent
The City of Holyoke Gas & Electric got their license extended for the Station No. 5 Hydroelectric Project until 2039, so they’ve officially stopped their plans to reapply right now. This means they won’t need to file new paperwork until 2034, saving time and effort for the next big step. No one objected, and the withdrawal became official on July 11, 2025.
Next: 2025-13447 — South Atlantic Fishery Management Council (Council)-Public Meetings
The South Atlantic Fishery Management Council is hosting two public meetings to talk about new rules for protecting coral reefs and managing shrimp fishing. They want to create a special Rock Shrimp fishing zone near the Oculina Bank to keep habitats safe while supporting fishermen. If you fish or care about ocean habitats in the South Atlantic, these changes could affect you soon!